Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
5.67
-0.06 (-1.05%)
At close: Jun 27, 2025, 4:00 PM
5.92
+0.25 (4.41%)
After-hours: Jun 27, 2025, 6:33 PM EDT
Kura Oncology Employees
Kura Oncology had 192 employees as of December 31, 2024. The number of employees increased by 50 or 35.21% compared to the previous year.
Employees
192
Change (1Y)
50
Growth (1Y)
35.21%
Revenue / Employee
$354,120
Profits / Employee
-$947,328
Market Cap
490.88M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KURA News
- 16 days ago - Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress - GlobeNewsWire
- 22 days ago - Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting - GlobeNewsWire
- 27 days ago - Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML - GlobeNewsWire
- 5 weeks ago - Kura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual Meeting - GlobeNewsWire
- 5 weeks ago - Kura Oncology to Participate in Three Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress - GlobeNewsWire
- 7 weeks ago - Kura Oncology to Participate in Bank of America Securities Healthcare Conference - GlobeNewsWire